Mirna Bou Hamdan
Overview
Explore the profile of Mirna Bou Hamdan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakr C, Abou Hassan F, Fakih L, Bou Hamdan M, Assaf S, Rahme D, et al.
Workplace Health Saf
. 2023 Dec;
72(2):48-59.
PMID: 38158826
Background: Healthcare workers (HCWs) faced substantial risk of infection during the COVID-19 outbreak. This study aims to determine the prevalence of anti-SARS-CoV-2 antibodies in a cross-sectional sample of HCWs as...
2.
Abou Hassan F, Bou Hamdan M, Melhem N
J Immunol Res
. 2023 May;
2023:7258585.
PMID: 37228441
Since its emergence, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a public health threat worldwide. While the majority of patients recover in 3-4 weeks, complications in severely ill patients,...
3.
Alkalamouni H, Abou Hassan F, Bou Hamdan M, Page A, Lott M, Matthews M, et al.
BMC Med Genomics
. 2023 Jan;
16(1):14.
PMID: 36707851
Background: The emergence of SARS-CoV-2 variants including the Delta and Omicron along with waning of vaccine-induced immunity over time contributed to increased rates of breakthrough infection specifically among healthcare workers...
4.
Abou Hassan F, Bou Hamdan M, Ali F, Melhem N
Epidemiol Infect
. 2023 Jan;
151:e23.
PMID: 36645257
The COVID-19 pandemic remains a public health problem threatening national and global health security. The socio-economic impact of COVID-19 was more severe on developing countries including Lebanon, especially due to...
5.
Abou Hassan F, Bou Hamdan M, El Asmar K, Melhem N
J Immunol Res
. 2022 Jan;
2022:1119611.
PMID: 35071606
Combined antiretroviral therapy (cART) increased the life expectancy of people living with HIV (PLHIV) and remarkably reduced the morbidity and mortality associated with HIV infection. However, non-AIDS associated comorbidities including...
6.
Hamad L, Kreidieh K, Bou Hamdan M, Nakouzi G, Yazbek S
J Immigr Minor Health
. 2020 Mar;
22(6):1347-1367.
PMID: 32172498
The aim of this systematic review is to provide physicians and researchers with a comprehensive list of reported genetic disorders in patients of Syrian origin-those who have become part of...
7.
Abou Hassan F, Bou Hamdan M, Melhem N
AIDS Res Hum Retroviruses
. 2019 Sep;
35(11-12):1123-1135.
PMID: 31510754
Combined antiretroviral therapy (cART) has increased the quality of life of people living with HIV (PLHIV). Consequently, the number of PLHIV >50 years is increasing worldwide. Patients on cART are...